ELOCON CREAM

Active substance: MOMETASONE FUROATE

View full screen / Print PDF » Download PDF ⇩

Transcript
06U071836 1/2

PACKAGE LEAFLET: INFORMATION FOR THE USER

MOMETASONE FUROATE 0.1% w/w Cream
Mometasone Furoate

Read all of this leaet carefully before you start using this medicine. Keep this leaet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side eects gets serious, or if you notice any side eects not listed in this leaet, please tell your doctor or pharmacist. In this leaet: 1. What MOMETASONE FUROATE is and what it is used for 2. Before you use MOMETASONE FUROATE 3. How to use MOMETASONE FUROATE 4. Possible side eects 5. How to store MOMETASONE FUROATE 6. Further information 1. WHAT MOMETASONE FUROATE IS AND WHAT IT IS USED FOR MOMETASONE FUROATE cream is one of a group of medicines called topical corticosteroids. It is classified as a potent corticosteroid. These medicines are put on the surface of the skin to reduce the redness and itchiness caused by certain skin problems. In adults and children, MOMETASONE FUROATE cream is used to reduce redness and itchiness caused by certain skin problems called psoriasis or dermatitis. Psoriasis is a skin disease in which itchy, scaly, pink patches develop on the elbows, knees, scalp and other parts of the body. Dermatitis is a condition brought on by the skin reacting to outside agents e.g. detergents, causing the skin to become red and itchy. 2. BEFORE YOU USE MOMETASONE FUROATE Do not use MOMETASONE FUROATE if you are allergic (hypersensitive) to mometasone furoate, any of the other ingredients of MOMETASONE FUROATE cream, or to other similar medicines. on any other skin problems as it could make them worse especially rosacea (a skin condition aecting the face) acne skin atrophy (thinning of the skin) dermatitis around the mouth genital itching nappy rash cold sores chickenpox shingles warts ulcerated skin wounds other skin infections Ask your doctor or pharmacist if you are not sure. Take special care with MOMETASONE FUROATE if your skin becomes irritated or sensitive after using MOMETASONE FUROATE, you should stop using it and tell your doctor. Pregnancy and breast-feeding You should tell your doctor if you are pregnant or breast-feeding, before you start using MOMETASONE FUROATE. 3. HOW TO USE MOMETASONE FUROATE Always use MOMETASONE FUROATE exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. MOMETASONE FUROATE is not recommended for children under the age of 2. Usually for adults and children, a thin layer of MOMETASONE FUROATE cream should be gently rubbed into the aected area of skin once a day. You should always follow these instructions when using MOMETASONE FUROATE: Do not use the cream on your face for more than 5 days. Do not apply the cream to children, on any part of their body, for more than 5 days. Do not put the cream under your childs nappy, as this makes it easier for the active drug to pass through the skin and possibly cause some unwanted eects.

06U071836.indd 1

11/30/12 8:27 AM

IN31GR/V
SUBMISSION PRODUCTNAME

(170 x 265 mm)
CODE

Folding Size 170 x 23

1.1

06U071836

MOMETASONE FUROATE

You should check with your doctor before covering the treated areas with a bandage or plaster. Treated areas on the face or in children should not be covered with a bandage or plaster. You should not use a large amount of cream on large areas of the body for a long time (for example every day for many weeks or months). Do not use in or around your eyes, including eye-lids. If you use more MOMETASONE FUROATE than you should If you (or somebody else) accidentally swallow the cream, it should not produce any problems. However, if you are worried, you should see your doctor. If you use the cream more often than you should, or on large areas of the body, it can aect some of your hormones. In children, this may aect their growth and development. If you have not used the cream as you were told to do and have used it too often and/or for a long time, you should tell your doctor. If you forget to use MOMETASONE FUROATE If you forget to use your cream at the right time, use it as soon as you remember, then carry on as before. If you stop using MOMETASONE FUROATE If you have been using MOMETASONE FUROATE for a long time and your skin problem seems to have got better, you should not suddenly stop using the cream. If you do, you may nd that your skin becomes red and you may notice stinging or burning. To avoid this, you should speak to your doctor as he will gradually reduce how often you need to use the cream until you stop treatment altogether. 4. POSSIBLE SIDE EFFECTS Like all medicines, MOMETASONE FUROATE can cause side eects, although not everybody gets them. A few people may nd that they suer from some of the following side eects after using MOMETASONE FUROATE: allergic skin reactions bacterial and secondary skin infections acne inammation and/or infection of the hair follicles thinning of the skin red marks with associated prickly heat loss of skin colour burning stinging itching tingling excessive hair growth softening of the skin and stretch marks Other side eects that may occur with topical corticosteroids are dry skin, skin irritation, dermatitis, dermatitis around the mouth, and small dilated blood vessels. If any of the side eects gets serious, or if you notice any side eects not listed in this leaet, please tell your doctor or pharmacist. 5. HOW TO STORE MOMETASONE FUROATE The cream should be stored below 25C. Store in the original package. Keep out of the reach of children. Do not use MOMETASONE FUROATE after the expiry date which is stamped on the pack. 6. FURTHER INFORMATION What MOMETASONE FUROATE 0.1% w/w Cream contains The active substance is mometasone furoate 0.1% w/w The other ingredients are: hexylene glycol; purified water; phosphoric acid; titanium dioxide; aluminium starch octenylsuccinate; white wax; white soft paran and hydrogenated soybean lecithin. What MOMETASONE FUROATE looks like and contents of the pack The cream is available in a tube containing 5, 15, 30 and 100g. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer The holder of the Marketing Authorisation is: Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK. The manufacturer is: Schering-Plough Labo NV, Heist-op-den Berg, Belgium. This leaet was last updated in November 2012
06U071836 2/2

06U071836.indd 2

11/30/12 8:27 AM

IN31GR/V
SUBMISSION PRODUCTNAME

(170 x 265 mm)
CODE

Folding Size 170 x 23

1.1

06U071836

MOMETASONE FUROATE

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web2)